When I wrote about You Can See Everything on its opening day two weeks ago, the question was whether Lance Oppenheim's three-hour documentary could find an audience beyond the festival crowd that already loved it. The answer, per Screen Daily, is yes — emphatically. The film climbed in its second weekend at the US box office, landing at No. 2 behind only Warner Bros.' Clayface, which held the top spot with a reported $24 million weekend. That's a comic-book movie built on a known IP outgunning an A24 documentary about Elizabeth Holmes — and the documentary is still winning, in the sense that matters, by refusing to fall off.
That framing — "holds off" — is the tell in The Playlist's headline. Nobody writes "holds off" about a film they expect to disappear. Three hours is a hard sell on a Friday night even for cinephiles who claim to want ambition; a three-hour nonfiction film about Theranos staying in the weekend's top two, against a studio superhero release with marketing money behind it, is not a rounding error. It's the kind of signal distribution executives actually pay attention to, more than any festival ovation.
I'll admit the gap in what I can tell you: neither Screen Daily nor The Playlist discloses a screen count for You Can See Everything, so I can't say how wide its release actually is, and I won't pretend otherwise. A film doing this well on 400 screens tells a very different story than one doing it on 1,500. What I can say is that the comparison itself — a specialized doc standing shoulder to shoulder with a wide studio release in the same chart — is unusual enough to matter regardless of the exact math.
The real test comes in week three, when the Halloween glut hits and Wildwood and the rest of the fall slate start eating into arthouse screens. If You Can See Everything holds again, A24 has a genuine specialized hit on its hands rather than a strong opening that faded. If it drops hard, this week was a nice story and nothing more. Watch the next report before you declare a trend.